retatrutide news recency 3 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase Trial New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide Results: 28.3% Weight Loss
Description
The clinical evidence base established for FDA-approved finished drug products does not automatically apply to compounded preparations
While compounded meds are affordable, brand-name options still run hundreds to thousands per month, and Hims doesnt provide reimbursement pathways
found exenatide did not significantly lower DBP compared to insulin glargine [88]
pmid:16319922 32
Is it an aesthetic choice
The real question isnt just whether they deliver results
